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Abstract 
S 100J3 is a calcium binding protein expressed primarily by astrocytes in the brain. In initiating studies of the toxic signalling pathways 
activated by high concentrations of S100/3, we previously demonstrated that treatment ofastrocytes with /xM S100fl results in a potent 
stimulation of the mRNA level and enzyme activity of inducible nitric oxide (NO) synthase, an enzyme previously implicated in glial 
pathology. We provide evidence here that NO formation stimulated by S100fl can lead to cell death in astrocytes, with characteristics 
defined for apoptosis. Incubation of astrocytes with S100j3 for 48 h results in an increased percentage of astrocytes undergoing apoptotic 
cell death, as determined with the TUNEL technique, assays of DNA fragmentation a d lactate dehydrogenase release. The cell death 
induced in response to S 100/3 addition correlates with the levels of NO formation, and an inhibitor of nitric oxide synthase attenuates the 
NO formation elicited by S100fl, as well as the cell death. Therefore, we propose that S100J3 has the potential to be trophic or toxic. 
Although S100fl may be involved in development, homeostasis and repair, chronic overexpression f the protein may mediate toxic 
responses or even cell death. 
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1. Introduction 
S 100/3 is a calcium binding protein expressed primarily 
by astrocytes in the brain. Recent studies have suggested 
that S100fl may play dual roles in regulation of cell 
functions, being beneficial to cells at low doses and detri- 
mental at high doses. It is well established that S 100/3 acts 
as a neurotrophic protein to promote survival and neuritic 
outgrowth from specific neuronal populations, and as a 
glial mitogen and morphogen [1]. These trophic activities 
require pM to nM concentrations of a disulfide-linked 
$100/3 dimer [1]. In its trophic role, S100/3 has been 
found to be beneficial during development of the nervous 
system and as a neuroprotective agent against neuronal 
insults. Increased S100/3 expression and secretion follow- 
ing acute glial activation in response to nerve injury may 
be one mechanism the brain uses in attempts to repair 
injured neurons. However, S100/3 may also reach concen- 
trations that are deleterious, for example, in neurodegener- 
ative diseases like Alzheirner's disease and Down Syn- 
* Corresponding author at address a.Fax: + 1 (312) 5030007; e-mail: 
vaneldik@ nwu.edu. 
drome where chronic glial activation occurs. S100/3 levels 
in severely affected brain regions of Alzheimer's patients 
are several-fold higher than in age-matched control sam- 
ples, and S100/3 overexpression correlates with the pattern 
of regional neuropathology and neuritic plaque involve- 
ment [2,3]. Although the local concentration of S100/3 in 
astrocytes surrounding neuritic plaques in Alzheimer's dis- 
ease has not been determined, the tissue levels are in the 
/zM range. 
In initial studies of potentially toxic signalling pathways 
activated by high concentrations of S100/3, we demon- 
strated [4] that treatment of cortical astrocytes with /xM 
concentrations of S100/3 results in a potent induction of 
the mRNA level and enzyme activity of inducible nitric 
oxide synthase (iNOS), an enzyme responsible for synthe- 
sis of nitric oxide (NO). In the nervous system, NO has 
been implicated in the regulation of cerebral blood flow, 
synaptic plasticity, and cell growth [5]. However, NO 
produced in abnormally high concentrations can be toxic 
to cells. For example, stimulation of astrocytic iNOS activ- 
ity by intedeukin-1/3 and interferon-T leads to enhanced 
NMDA receptor-mediated neurotoxicity [6]. A body of 
studies also implicates NO in a number of diseases ranging 
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from septic shock and diabetes to neurodegenerative disor- 
ders such as Huntington's disease and Alzheimer's disease 
[7]. 
The aim of the present study was to determine the 
extent of S100fl-stimulated NO generation among astro- 
cytes from different brain regions and the consequences of 
NO release on astrocyte function. It has been reported that 
/zM concentrations of an S100 isoform can induce apop- 
totic cell death in PC12 cells through sustained increases 
in intracellular Ca 2+ concentrations [8]. A link between 
NO formation and apoptosis has also been proposed for 
many other cell types, such as neurons and macrophages 
[9,10]. Apoptosis, or programmed cell death, is character- 
ized by typical morphological alterations, including cell 
shrinking, membrane blebbing, widespread chromatin con- 
densation and segregation into distinct masses that can 
form blisterlike protrusions [11]. A biochemical character- 
istic of ceils undergoing apoptosis is the cleavage of 
genomic DNA into internucleosomal fragments, which can 
be demonstrated by agarose gel electrophoresis howing a 
nucleosomal DNA ladder. Recently, several techniques 
have been developed to sensitively label apoptotic ells, 
based on the increased number of hydroxyl-end groups in 
the cleaved DNA during apoptosis. For example, the 
TUNEL (terminal transferase-mediated dUTP-biotin nick 
end labeling) technique correlates well with other markers 
of apoptosis, including morphological changes and nuclear 
fragmentation. We report here the effects of S100fl on 
iNOS activity in cultured astrocytes derived from various 
regions of brain, and more detailed studies on hippocampal 
astrocyte morphology and cell viability in response to 
stimulation of iNOS by S100fl. We provide evidence that 
stimulation of astrocytes with S100fl can lead to cell 
death, with characteristics defined for apoptosis, and that 
the apoptotic ell death occurs in an NO-dependent man- 
ner. 
2. Materials and methods 
2.1. Purification of proteins 
Bovine S100fl was expressed from a synthetic gene in 
E. coli [12], and purified and characterized as previously 
described [4,13]. S100fl was dialyzed and concentrated 
against phosphate-buffered saline (PBS) containing 5% 
polyethylene glycol 8000, and stored in aliquots at - 20°C. 
Protein concentrations were determined by the method of 
Lowry et al. [14] using bovine serum albumin as standard. 
2.2. Cell culture 
Primary astrocytes from different regions of the brain 
were prepared from neonatal (1 day old) Sprague-Dawley 
rat pups as described by Levison and McCarthy [15]. 
Briefly, the cerebral cortex, hippocampus, cerebellum, 
striatum, midbrain and thalamus from one rat pup was 
dissected out and trypsinized, and cells were passed through 
a 136 /xm and then a 40 /zm nylon mesh. Cells were 
seeded into either two 100 mm tissue culture plates 
(cerebral cortex) or one 60 mm plate (the other brain 
regions) in alpha-MEM (Gibco, Grand Island, NY) con- 
taining 10% fetal bovine serum (Hyclone, Logan, UT) and 
antibiotics (100 U/ml  penicillin and 100 /xg/ml strepto- 
mycin). Cells were maintained at 37°C in a humidified 5% 
CO2-containing atmosphere until 11 days in culture, then 
trypsinized and re-plated into 100 mm plates at a density 
of ~ 5 X 105 cells per plate, and grown until confluence. 
2.3. Treatment of cells with SlOOfl 
Confluent secondary astrocytes were trypsinized and 
re-plated into 24-well plates at 1 X 105 cells per well (for 
the nitrite assay in different brain regions), into 8-well 
chamberslides at 5 X l 0  4 cells per well (for the nitrite, 
LDH and TUNEL assay in hippocampus), or into 60 mm 
plates at 2 X 106 cells per plate (for the DNA fragmenta- 
tion assay). Cells were allowed to attach for 4 hr, at which 
time S100fl was added into the culture medium, and cells 
were grown for an additional 48 h. Some cultures were 
treated with lipopolysaccharide (LPS; 10 /zg/ml), S- 
nitroso-N-acetylpenicillamine (SNAP; 2 mM) or PBS in- 
stead of S 100fl, and these cultures erved as positive (LPS 
and SNAP) and negative (PBS) controls, respectively. 
When the NOS inhibitors, N-nitro-L-arginine methylester 
(L-NAME, 1 mM)and N-nitro-o-arginine methylester (o- 
NAME, 1 mM) were used, these agents were added to the 
cultures at the same time as the S100/3. 
2.4. Measurement ofNO by nitrite assay 
NO production was assessed as previously described [4] 
by measurement of nitrite (a stable oxidation product of 
NO) in the conditioned medium, based on the Griess 
reaction [16]. 
2.5. Assay of apoptotic ells by TUNEL labeling 
After 48 h of incubation with S100/3, hippocampal 
astrocytes were fixed in ice-cold methanol for 3 min. 
Sensitive and specific staining of the high concentrations 
of 3'-OH ends of fragmented DNA that are localized in 
apoptotic bodies was performed using the ApopTag Fluo- 
rescein Kit (Oncor, Gaithersburg, MD) as described by the 
manufacturer. At the end of the TUNEL labeling, cells 
were counterstained with the chromosome-binding dye 
4'6'-diamidino-2-phenylindole (DAPI, 0.05 /xg/ml). The 
number of total cells in each field (at 63X magnification) 
were counted by using a UV filter (blue color), and 
TUNEL positive cells were counted by using a fluorescein 
filter (green) on a Leitz Diaplan fluorescent microscope. 
Microscope fields were chosen randomly, and a total of 
400-500 cells were counted for each treatment. Fluores- 
cence micrographs of phase contrast and TUNEL labeled 
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cells were taken on a Zeiss Axioskop fluorescent micro- 
scope. 
2.6. Assay of DNA fragmentation by agarose gel elec- 
trophoresis 
After 48 h incubation wil:h S100/3, hippocampal astro- 
cytes were scraped off the culture plates with a rubber 
policeman, and centrifuged at 1500 × g for 5 min. Cell 
pellets were resuspended in 250 /zl of TE buffer (10 mM 
Tris-HC1, lmM EDTA, pH 8.0), and then an additional 
250/z l  of lysis buffer (5 mM Tris-HC1, 20 mM EDTA, pH 
8.0, 0.5% Triton X-100) was added. Cells were allowed to 
lyse at 4°C for at least 30 rain. The DNA fragments 
(supernatant) were separated from intact chromatin (pellet) 
by centrifugation at 13000 × g for 15 rain. Supernatant 
was precipitated with 50 p,1 of 5 M NaCI and 1 ml of 
ice-cold ethanol at - 20 ° overnight, and then centrifuged at 
13 000 × g for 20 min. The resulting pellet was incubated 
in 500/z l  of TE buffer containing 400/zg /ml  RNase A at 
37°C for 30 min. Samples were extracted with an equal 
volume of phenol/chloroform/isoamyl alcohol (25:24: I), 
and once again with an equal volume of chloroform. The 
DNA was isolated by precipitation with 1 / I0  volume of 5 
M NaC1 and 2 volumes of ethanol, followed by centrifuga- 
tion at 13 000 × g for 20 min and air drying. DNA pellet 
was dissolved in 10/xl  TE buffer plus 5 /xl DNA loading 
buffer (0.4% bromphenol blue, 60% sucrose, 50 mM 
EDTA). Electrophoresis was carded out on a 1% agarose 
gel containing 1 /xg/ml ethidium bromide, and run in 
buffer composed of 40 mM Tris-acetate, pH 8.0, 1 mM 
EDTA for 2 h at I00 V. Pictures were taken under UV 
transillumination. 
2.7. Assay of lactate dehydrogenase activity 
Lactate dehydrogenase (LDH) activity in the culture 
medium was assayed based on the reduction of pyruvate to 
lactate and the oxidation of NADH to NAD +, resulting in 
a decrease in absorbance at 340 nm (Sigma diagnostic kit). 
2.8. Data analysis 
The significance of differences was determined with a 
Student's t-test. Statistical significance was established at 
a level of P values < 0.05. 
3. Results 
3.1. Stimulation of iNOS in astrocytes derived from vari- 
ous brain regions 
We have previously shown [4] that treatment of cerebral 
cortical astrocytes with S100/3 enhances NOS activity and 
release of NO, as determined by the increase in accumula- 
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Fig. 1. Stimulation of iNOS in rat astrocytes derived from various brain 
regions. Astrocyte cultures from cerebral cortex, cerebellum, hippocam- 
pus, striatum, midbrain and thalamus were incubated without (control) or 
with 40 p.g/ml S100/3 at 37°C for 48 h. The iNOS activity was 
measured by assaying the nitrite concentrations accumulated in the 
culture medium. Data represent the mean_+SEM from 4 individual 
experiments performed in triplicates. * P < 0.05 vs. control. 
tion of the stable NO metabolite nitrite in the conditioned 
medium. Measurement of NOS enzyme activity and NOS 
mRNA levels confirmed that the NOS stimulated by S 100/3 
addition is the Ca2+-independent i ducible iNOS isoform 
[4]. Fig. 1 shows that, in addition to cerebral cortex, the 
astrocytes derived from hippocampus, cerebellum, stria- 
rum, midbrain and thalamus were also able to respond to 
S100/3 addition by generation of NO. The levels of nitrite 
accumulation stimulated by S100fl addition were similar 
to those induced by 10 /xg/ml of LPS in the correspond- 
ing regions (data not shown). The magnitude of increase in 
nitrite levels, in S100/3-treated vs control cultures, was 
highest in striatum (~ 10-fold), as compared to those for 
cerebral cortex, cerebellum and midbrain (~ 6-fold), and 
for hippocampus and thalamus (~ 3-fold) (Fig. 1). 
250- 
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Fig. 2. Dose-response curves of S100/3-stimulated nitrite accumulation 
and LDH release in rat hippocampal astrocyte cultures. Astrocytes were 
treated without or with increasing concentrations f S100fl at 37°C for 48 
h. Nitrite levels (left panel) or LDH activity (right panel) in culture 
medium were determined. The values from S l00fl-treated cultures are 
expressed asa percentage of the values from PBS-treated control cultures, 
and represents one of 9 independent experiments. 
242 J. Hu, L.J. Van Eldik / Biochimica et Biophysica Acta 1313 (1996) 239-245 
3.2. SIO0~ dose-dependent NO formation and LDH re- 
lease 
To examine the potential relationship between S100fl- 
stimulated NO release and astrocyte integrity, we per- 
formed more detailed studies on hippocampal astrocyte 
cultures. Treatment of hippocampal astrocytes with in- 
creasing concentrations of S100/3 resulted in a dose-de- 
pendent increase in nitrite accumulation (Fig. 2). The 
maximal increase in nitrite levels was achieved by 60 
/zg/ml of S100/3 in the concentration range tested, and 
the concentration required for eliciting 50% of the maxi- 
mal response was ~ 20 /zg/ml. These values are similar 
to those reported for cerebral cortical astrocytes [4]. S 100/3 
treatment also caused a dose-dependent slight increase in 






Fig. 3. Cell morphological nd nuclear changes induced by S100fl, LPS and SNAP. Hippocampal astrocyte cultures were incubated with PBS (control), 
S100/3 (40 p~g/ml), LPS (10/xg/ml)  or SNAP (2 mM) at 37°C for 48 h. Left panels how phase contrast and fight panels how fluorescence micrographs 
of cells stained for fragmenting DNA with the TUNEL method. All pictures were taken at the same magnification. Fluorescence micrographs were exposed 
for the same length of time. Magnification bar = 100 /zrn. 
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Fig. 4. Dose-dependent increase in apoptotic cells induced by SI00/3. 
Hippocampal strocytes were treated with increasing concentrations of 
S100/3 at 37°C for 48 h. Cells were then stained with the TUNEL method 
to detect apoptotic cells, and counterstained with DAPI (0.05 /~g/ml) to 
label total cells. The number of apoptotic cells as a percentage of the total 
cells was then calculated. Data shown are representative results from one 
of three independent experiments. 
suggest hat a loss of cell membrane integrity and conse- 
quent release of the cytoplasmic enzyme LDH may be 
related to the generation of NO in cultured hippocampal 
astrocytes. 
3.3. Evidence of apoptosis upon NO formation 
To evaluate the patterns of cell death in response to 
S100/3 treatment, we examined cell morphology under 
light microscopy, and DNA characteristics with the TUNEL 
method. As demonstrated in Fig. 3, incubation of hip- 
pocampal astrocytes with 40 /zg/ml S100/3 for 48 h 
induced morphological changes in some of the cells. The 
morphological lterations included exaggerated blisterlike 
cytoplasmic protuberances, cell shrinking, and membrane 
blebbing, characteristics of apoptotic ell bodies. The cells 
undergoing morphologica] changes were also positively 
stained with TUNEL (Fig. 3), indicative of available T-OH 
end groups in DNA undergoing fragmentation during 
apoptosis. Furthermore, the percentage of cells undergoing 
apoptosis in response to ,S100/3 treatment was enhanced 
with increasing S100/3 concentrations (Fig. 4). The maxi- 
mal induction of apoptotic ells was 7-22% at 60 ~g/ml  
of S100/3, in comparison with 1-4% apoptotic ells in 
non-treated cultures. The potency of S100/3 in induction 
of astrocytic apoptosis is :similar to that for stimulation of 
nitrite accumulation and LDH release. Moreover, the apop- 
totic pattern of the cellular DNA after exposure of cells to 
S100/3 was confirmed by agarose gel electrophoresis. As
shown in Fig. 5, treatment of cells with 60 /xg/ml of 
S100/3 caused DNA fragmentation, resulting in fragment 
laddering of multiples of ~ 180 base pairs, which indi- 
cates an internucleosomalL cleavage of DNA. In contrast, 
little DNA fragmentation was detected in control cultures 
(Fig. 5). 
Fig. 5. DNA laddering induced by S100/3. Hippocampal astrocytes were 
incubated with PBS, S100/3 (60 /~g/ml), or SNAP (2 raM) for 48 h. 
DNA fragments were separated from intact chromatin, extracted, and 
examined by agarose gel electrophoresis. Each lane was loaded with 
DNA corresponding to 2× 106 initially plated cells. Molecular weight 
(MW) standards are a 100 bp DNA ladder. 
To provide more direct evidence that the S100/3-stimu- 
lated apoptosis was related to the generation of NO, we 
tested the effects of S100/3 in the presence of an NOS 
inhibitor. The S100/3-elicited LDH release and increase in 
apoptotic ells were suppressed when the astrocytes were 
250 - 14 
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Fig. 6. Inhibition of S100/3-induced cell death by NOS inhibitor. Hip- 
pocampal astrocytes were incubated for 48 h with PBS or with S100/3 
(60/xg/ml)  in the presence or absence of the NOS inhibitor L-NAME (1 
raM) or the inactive isomer D-NAME (1 mM). LDH activity (left panel) 
was measured in the culture medium, and the % apoptotic ells (right 
panel) were determined by the TUNEL method. Data shown are represen- 
tative results from one of four (LDH) or three (apoptosis) independent 
experiments. 
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Table 1 
Stimulation of nitrite accumulation, LDH release, 
S 100fl and NO-generating a ents 
and apoptosis by 
Nitrite (/~M) LDH (U/l) Apoptosis 
(% of total cells) 
Control 12.1 +3.0 (9) 66.64-9.1 (9) 1.7+0.7 (4) 
S100/3,60~g/ 20.64-3.6(9)* 90.24-18.6(9) 12.1:23.6(4)* 
ml 
LPS, 10/xg/ml 28.6:24.7 (9) * 100.84-15.7 (9) * 13.8_+ 1.3 (4) * 
SNAP, 2 mM - 147.24-30.4(9) * 26.4_+3.8 (4) * 
Sodium nitrite, - 75.6_+ 22.0 (4) 0.9 4- 0.4 (3) 
lmlVl 
Number in parenthesis indicates the numbers of individual experiments 
performed. 
* P < 0.05 vs. values in control. 
incubated with S 100/3 in the presence of the specific NOS 
inhibitor L-NAME, but not in the presence of the inactive 
isoform of the NOS inhibitor D-NAME (Fig. 6). These data 
indicate that stimulation of iNOS activity is involved in 
S100/3-induced responses, and that subsequent cell death 
correlates with the NO formation. 
To substantiate further the observation that apoptotic 
cell death can be induced through formation of NO, astro- 
cyte cultures were treated with LPS or SNAP. These 
compounds are known to generate NO through activation 
of astrocytic iNOS and chemical release of NO, respec- 
tively. As shown in Fig. 3, similar apoptotic morphology 
and TUNEL labeling characteristics were observed after 
incubation of hippocampal strocytes with l0 /xg/ml LPS 
or 2 mM SNAP for 48 h. These compounds were also able 
to enhance LDH activity in culture medium (Table 1). 
However, neither apoptosis nor LDH activity was stimu- 
lated by direct addition of the NO metabolite nitrite in its 
NaNO 2 form. Taken together, the results suggest that NO, 
formed endogenously through activation of iNOS or added 
exogenously by using an NO-releasing compound, induces 
astrocytes to undergo apoptotic ell death. 
4. Discussion 
Our data have shown that/~M concentrations of S 100/3 
can be toxic to cells, leading to an induction of astrocytic 
cell death. This S 100r-induced cell death shows character- 
istics of apoptosis, as evidenced by morphological changes, 
DNA labeling and fragmentation patterns. The S100/3- 
stimulated cell death correlates with the levels of nitrite 
accumulation in the culture medium, is blocked by the 
NOS inhibitor L-NAME, and is mimicked by two other 
NO-generating compounds, LPS and SNAP. Altogether, 
our results suggest hat high concentrations of S 100/3 can 
induce astrocytic apoptosis through an NO-dependent 
mechanism. 
NO produced by activation of iNOS has been shown to 
be a pathological mechanism in different experimentally 
induced models of neurological disease [17]. A link be- 
tween NO generation and apoptosis has previously been 
demonstrated for many cell types, including neurons and 
macrophages [9,10]. For example, incubation of 
macrophage cells with LPS and interferon-y results in 
activation of iNOS and generation of NO, leading to 
internucleosomal DNA fragmentation a d cell morphologi- 
cal alterations consistent with apoptosis [10,18]. However, 
few previous reports have examined the effects of NO 
release on astrocytes. In our experiments, S100fl-treated 
astrocytes showed morphological nd biochemical changes 
similar to those seen in macrophage cells undergoing 
apoptosis in response to NO generation. In addition, the 
induction of astrocytic apoptosis by LPS and SNAP indi- 
cates that endogenously generated or exogenously supplied 
NO is able to cause cell death. Thus, these results show 
that astrocytes can undergo apoptosis upon stimulation of 
iNOS and generation of large amounts of NO. 
The mechanisms involved in S100/3 stimulation of 
iNOS and subsequent cell death are not defined yet. It has 
been reported [8] that an isoform of S100 can induce 
apoptosis in PC12 cells through sustained increases in 
intracellular Ca 2+ concentrations. In astrocytes, S100/3 
has been shown [13] to stimulate an increase in intra- 
cellular Ca 2+ concentrations, with a rapid and transient 
elevation probably reflecting release of Ca 2+ from intra- 
cellular Ca 2÷ stores, and a sustained component reflecting 
a Ca 2÷ influx from the extracellular space. The relation- 
ship of intracellular Ca 2÷ levels to S100/3-induced apopto- 
sis in astrocytes has not been examined at present. How- 
ever, changes in intracellular ion homeostasis leading to 
apoptosis have been reported for many cell types [19]. 
Activation of Ca2+-dependent endonucleases or calmod- 
ulin-regulated enzymes in response to elevation of intra- 
cellular Ca 2÷ levels are potential mechanisms by which 
apoptosis might occur. In addition, Ca 2÷ is involved in 
regulation of expression of a number of genes which may 
be relevant to the apoptosis process, including proto- 
oncogenes uch as c-fos [20] and c-myc [2l]. Although 
S100fl has been reported to stimulate c-myc and c-fos 
expression [22], whether this mechanism is involved in 
S100/3-mediated cell death is unknown. The molecular 
mechanisms by which S 100/3 stimulates iNOS activity and 
leads to apoptosis in astrocytes await further investigation. 
It should be noted that the S100/3-induced astrocytic 
cell death process is likely to be extremely complex. We 
cannot rule out the possibility, for example, that S 100/3-in- 
duced cell death includes a necrotic death pathway as well 
as apoptosis. NO is a free radical that can interact with cell 
membrane lipids and cause membrane damage. It has also 
been demonstrated that NO can affect mitochondrial in- 
tegrity and function [23]. In addition, in some experiments, 
we have seen generation of NO in response to S100/3 
without any apparent effect on cellular viability. Because 
of the complex biology of NO, it is likely that the suscepti- 
bility of a cell to NO-mediated toxicity will vary depend- 
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ing on variables such as time of exposure to NO, concen- 
tration and redox forms of NO released, availability of 
reactive oxygen species and antioxidant defenses, changes 
in ion homeostasis, and presence of other cytotoxic or 
cytoprotective agents. 
Another potentially complicating variable is the activa- 
tion state of the astrocytes. Activated astrocytes are distin- 
guished from normal astrocytes by their larger size and 
more prominent glial processes [24,25]. In a variety of 
models of brain injury and in neurodegenerative disease 
such as Alzheimer's disease, glial activation is a prominent 
and consistent feature. Activated glia show upregulation of 
a number of proteins that themselves can stimulate NO 
generation, including interferon-T, interleukin-1, and 
S100/3 [25]. An interesting phenomenon that we have 
observed with S100fl-treated astrocytes is that S100/3 
induces NO, LDH release and cell death without inducing 
morphological alterations consistent with glial activation. 
In contrast, we have found that amyloid-fl can induce 
astrocyte activation and NO generation, but not LDH 
release (unpublished observations). The temporal sequence 
and mechanistic relationships among NO release, glial 
activation and cell death are completely unknown. How- 
ever, it is likely that the mechanisms by which NO is 
generated and the cellular consequences of NO release will 
depend on a complex interplay involving temporal and 
spatial interactions among the NO-generating proteins, po- 
tential cross-talk among signal transduction pathways, the 
glial activation state, and cell-cell interactions. 
Our future studies will examine some of these potential 
interactions for S100fl by testing the effects of other 
cytokines, glial activation state, and presence of other cell 
types on the ability of S100fl to modulate iNOS activity in 
astrocytes. The data reported here demonstrate that treat- 
ment of astrocytes with /zM S100/3 can lead to apoptotic 
cell death in astrocytes via a NO-dependent pathway. The 
consequences of S100fl-induced NO release on the neuron 
have not been studied yet. However, if S100fl stimulates 
astrocytic iNOS activity in vivo and subsequently causes 
cell death, this might be relevant to neurodegenerative 
diseases like Alzheimer's disease where S 100/3 levels are 
elevated selectively in those brain regions exhibiting neu- 
ropathology. Recent studies; have shown [26] that apoptosis 
can occur in both neurons and astrocytes in hippocampal 
sections derived from the brain of Alzheimer's disease 
patients. The relationship between increased S100/3 levels 
and neuropathology is not known. It may be that the 
up-regulation of S 100/3 in activated glia is initially benefi- 
cial, as part of a compensatory response of the brain to 
repair injured neurons through S100fl 's neurotrophic and 
neuroprotective roles. However, excessive or chronic over- 
expression of S100/3 may have deleterious consequences 
for the neurons. Our results showing that S100fl can 
stimulate astrocytic cell death provides a precedent for 
how excessive S100/3 might contribute to neuropathology. 
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